Deerfield Management Company, L.P. (Series C) Rvl Pharmaceuticals PLC Transaction History

Deerfield Management Company, L.P. (Series C)

  • $5.38 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$2.34 - $4.28 $1.98 Million - $3.62 Million
-846,048 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$3.6 - $8.75 $1.05 Million - $2.56 Million
-292,208 Reduced 25.67%
846,048 $3.05 Million
Q4 2018

Feb 14, 2019
BUY
$6.25 - $9.2 $7.11 Million - $10.5 Million
1,138,256 New
1,138,256 $8.82 Million

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0
View Full List

About RVL Pharmaceuticals plc

RVLP Quotes by TradingView
  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email